{"hands_on_practices": [{"introduction": "The dynamic level of any post-translational modification is governed by a 'push-pull' mechanism: the balance between the enzymes that add the modification and those that remove it. Understanding this balance is the first step toward modeling complex signaling networks. This foundational exercise ([@problem_id:2839222]) challenges you to derive, from first principles, the steady-state outcome of a simple phosphorylation-dephosphorylation cycle, revealing how the kinetic properties of the kinase and phosphatase dictate the final phosphorylated fraction of a target protein.", "problem": "A pool of a transcription factor with a single phosphorylation site is regulated by a kinase and a phosphatase in a living cell. Denote the unphosphorylated form by $S$ and the phosphorylated form by $S_{\\mathrm{p}}$. The total concentration $S_{\\mathrm{T}}$ is conserved on the time scale of interest, so that $S_{\\mathrm{T}} = [S] + [S_{\\mathrm{p}}]$. The kinase converts $S$ to $S_{\\mathrm{p}}$ and obeys Michaelis–Menten kinetics with maximal velocity $V_{1}$ on its substrate $S$ and Michaelis constant $K_{1}$. The phosphatase converts $S_{\\mathrm{p}}$ to $S$ and obeys Michaelis–Menten kinetics with maximal velocity $V_{2}$ on its substrate $S_{\\mathrm{p}}$ and Michaelis constant $K_{2}$. Assume a regime in which both enzymes are far from saturation with their respective substrates, specifically $[S] \\ll K_{1}$ and $[S_{\\mathrm{p}}] \\ll K_{2}$, and that synthesis and degradation of the transcription factor are negligible on this time scale.\n\nStarting only from the standard Michaelis–Menten rate law and mass conservation, compute the steady-state phosphorylated fraction $f^{*} \\equiv \\dfrac{[S_{\\mathrm{p}}]}{S_{\\mathrm{T}}}$ as a closed-form expression in terms of $V_{1}$, $K_{1}$, $V_{2}$, and $K_{2}$. Express your final answer as a simplified symbolic expression. Do not round your answer.", "solution": "The problem statement is validated as scientifically grounded, well-posed, and complete. It describes a standard model of a covalent modification cycle in cell biology, specifically a phosphorylation-dephosphorylation cycle operating under first-order kinetic conditions. The assumptions are clearly stated and physically plausible within certain biological regimes. We may proceed with the derivation.\n\nThe system involves a transcription factor existing in two states: unphosphorylated, $S$, and phosphorylated, $S_{\\mathrm{p}}$. The total concentration, $S_{\\mathrm{T}}$, is constant:\n$$S_{\\mathrm{T}} = [S] + [S_{\\mathrm{p}}]$$\nThe rate of change of the concentration of the phosphorylated form, $[S_{\\mathrm{p}}]$, is determined by the difference between its rate of formation by the kinase and its rate of removal by the phosphatase. The rate equation is:\n$$\\frac{d[S_{\\mathrm{p}}]}{dt} = v_{1} - v_{2}$$\nwhere $v_{1}$ is the velocity of the kinase reaction and $v_{2}$ is the velocity of the phosphatase reaction.\n\nThe kinase reaction, $S \\rightarrow S_{\\mathrm{p}}$, follows Michaelis-Menten kinetics with substrate $S$:\n$$v_{1} = \\frac{V_{1} [S]}{K_{1} + [S]}$$\nThe phosphatase reaction, $S_{\\mathrm{p}} \\rightarrow S$, follows Michaelis-Menten kinetics with substrate $S_{\\mathrm{p}}$:\n$$v_{2} = \\frac{V_{2} [S_{\\mathrm{p}}]}{K_{2} + [S_{\\mathrm{p}}]}$$\nThe problem states that both enzymes are far from saturation with their respective substrates. This is expressed by the strict inequalities $[S] \\ll K_{1}$ and $[S_{\\mathrm{p}}] \\ll K_{2}$. Under these conditions, the Michaelis-Menten rate laws simplify to first-order kinetics with respect to the substrate concentration.\n\nFor the kinase, since $[S] \\ll K_{1}$, the denominator $K_{1} + [S]$ can be approximated as $K_{1}$. The rate law becomes:\n$$v_{1} \\approx \\frac{V_{1} [S]}{K_{1}}$$\nFor the phosphatase, since $[S_{\\mathrm{p}}] \\ll K_{2}$, the denominator $K_{2} + [S_{\\mathrm{p}}]$ can be approximated as $K_{2}$. The rate law becomes:\n$$v_{2} \\approx \\frac{V_{2} [S_{\\mathrm{p}}]}{K_{2}}$$\nThese expressions describe linear, or first-order, kinetics. The ratios $\\frac{V_{1}}{K_{1}}$ and $\\frac{V_{2}}{K_{2}}$ represent the apparent first-order rate constants for the phosphorylation and dephosphorylation reactions, respectively.\n\nAt steady state, the concentrations of all species are constant, which implies that the net rate of change of $[S_{\\mathrm{p}}]$ is zero. Let the steady-state concentrations be denoted by $[S]^{*}$ and $[S_{\\mathrm{p}}]^{*}$. The steady-state condition is:\n$$\\frac{d[S_{\\mathrm{p}}]}{dt} = 0 \\implies v_{1} = v_{2}$$\nSubstituting the simplified rate laws into the steady-state equation gives:\n$$\\frac{V_{1} [S]^{*}}{K_{1}} = \\frac{V_{2} [S_{\\mathrm{p}}]^{*}}{K_{2}}$$\nWe have a system of two equations for the two unknown steady-state concentrations, $[S]^{*}$ and $[S_{\\mathrm{p}}]^{*}$:\n$1.$ $\\frac{V_{1} [S]^{*}}{K_{1}} = \\frac{V_{2} [S_{\\mathrm{p}}]^{*}}{K_{2}}$\n$2.$ $S_{\\mathrm{T}} = [S]^{*} + [S_{\\mathrm{p}}]^{*}$\n\nFrom the conservation equation ($2$), we express $[S]^{*}$ in terms of $[S_{\\mathrm{p}}]^{*}$ and $S_{\\mathrm{T}}$:\n$$[S]^{*} = S_{\\mathrm{T}} - [S_{\\mathrm{p}}]^{*}$$\nSubstitute this expression for $[S]^{*}$ into the steady-state rate equality ($1$):\n$$\\frac{V_{1}}{K_{1}} (S_{\\mathrm{T}} - [S_{\\mathrm{p}}]^{*}) = \\frac{V_{2}}{K_{2}} [S_{\\mathrm{p}}]^{*}$$\nOur goal is to solve for the steady-state phosphorylated fraction, $f^{*} \\equiv \\frac{[S_{\\mathrm{p}}]^{*}}{S_{\\mathrm{T}}}$. First, we solve the algebraic equation for $[S_{\\mathrm{p}}]^{*}$:\n$$\\frac{V_{1}}{K_{1}} S_{\\mathrm{T}} - \\frac{V_{1}}{K_{1}} [S_{\\mathrm{p}}]^{*} = \\frac{V_{2}}{K_{2}} [S_{\\mathrm{p}}]^{*}$$\nGroup the terms containing $[S_{\\mathrm{p}}]^{*}$:\n$$\\frac{V_{1}}{K_{1}} S_{\\mathrm{T}} = \\left(\\frac{V_{1}}{K_{1}} + \\frac{V_{2}}{K_{2}}\\right) [S_{\\mathrm{p}}]^{*}$$\nIsolate $[S_{\\mathrm{p}}]^{*}$:\n$$[S_{\\mathrm{p}}]^{*} = \\frac{\\frac{V_{1}}{K_{1}} S_{\\mathrm{T}}}{\\frac{V_{1}}{K_{1}} + \\frac{V_{2}}{K_{2}}}$$\nNow, we compute the desired fraction $f^{*}$ by dividing both sides by $S_{\\mathrm{T}}$:\n$$f^{*} = \\frac{[S_{\\mathrm{p}}]^{*}}{S_{\\mathrm{T}}} = \\frac{\\frac{V_{1}}{K_{1}}}{\\frac{V_{1}}{K_{1}} + \\frac{V_{2}}{K_{2}}}$$\nTo obtain the simplified final form, we multiply the numerator and the denominator by the product $K_{1} K_{2}$:\n$$f^{*} = \\frac{\\frac{V_{1}}{K_{1}} (K_{1} K_{2})}{\\left(\\frac{V_{1}}{K_{1}} + \\frac{V_{2}}{K_{2}}\\right) (K_{1} K_{2})} = \\frac{V_{1} K_{2}}{V_{1} K_{2} + V_{2} K_{1}}$$\nThis is the closed-form expression for the steady-state phosphorylated fraction in terms of the given kinetic parameters.", "answer": "$$\\boxed{\\frac{V_{1} K_{2}}{V_{1} K_{2} + V_{2} K_{1}}}$$", "id": "2839222"}, {"introduction": "Theoretical models are powerful, but they are only as good as the experimental data used to validate them. To connect our understanding of kinetics to real biology, we need robust methods to precisely measure PTM stoichiometry within the cell. This practice ([@problem_id:2839183]) guides you through the logic of a gold-standard quantitative proteomics technique—Stable Isotope Labeling by Amino acids in Cell culture (SILAC)—challenging you to derive the mathematical basis for accurately determining phosphorylation occupancy changes from mass spectrometry data.", "problem": "A kinase signaling experiment is planned to quantify site-specific phosphorylation occupancy before and after a stimulus using Stable Isotope Labeling by Amino acids in Cell culture (SILAC) and mass spectrometry (MS). You will design a spike-in SILAC strategy and then derive, from first principles, how to compute phosphorylation occupancy in the stimulated sample from measured light-to-heavy peptide ratios.\n\nDesign a scientifically justified SILAC-MS workflow that enables estimation of phosphorylation occupancy for a single tryptic site-containing peptide in a stimulated sample relative to a heavy-labeled reference prepared from cells under baseline conditions. Your design must ensure that ionization efficiency differences between the phosphorylated peptide and its nonmodified counterpart do not bias the occupancy estimate. You may assume the following well-tested facts: (i) proteolysis yields a site-containing phosphorylated peptide and the corresponding nonmodified counterpart that are chemically identical except for the phosphate group; (ii) the MS signal for a given peptide chemical form is proportional to its molar amount times a constant response factor that is identical for its light and heavy isotopologs; (iii) the heavy-labeled reference proteome is mixed at a fixed known amount into each light-labeled experimental sample immediately prior to MS analysis.\n\nStarting from core definitions and conservation principles, and without invoking any unproven shortcut formulas, do the following:\n\n- Define the phosphorylation occupancy in a sample as $p = \\frac{P}{P + U}$, where $P$ and $U$ are the molar amounts of the phosphorylated and nonmodified site-containing peptides, respectively. Let the heavy-labeled reference (baseline) have occupancy $p_{r}$ and total site-containing peptide amount $T_{r}$, and the light-labeled stimulated sample have occupancy $p_{s}$ and total amount $T_{s}$.\n- Use proportional MS response and the SILAC spike-in to relate the experimentally observed light-to-heavy ratios for the phosphorylated peptide, $R_{P}$, and the nonmodified peptide, $R_{U}$, to the underlying amounts $P_{s}, P_{r}, U_{s}, U_{r}$.\n- By eliminating nuisance proportionality constants and any unknown mixing factors, derive from first principles a closed-form expression for $p_{s}$ in terms of $R_{P}$, $R_{U}$, and $p_{r}$ only.\n- Then, given measured values $R_{P} = 3.2$, $R_{U} = 0.80$, and a known baseline occupancy $p_{r} = 0.25$, compute $p_{s}$. Express $p_{s}$ as a single exact fraction or a decimal fraction. If you choose a decimal, no rounding is required because an exact fractional form exists.", "solution": "The problem presents a valid and well-posed question in the field of quantitative proteomics. It is scientifically grounded, objective, and contains sufficient information for a rigorous derivation and solution. I shall proceed.\n\nThe task is to design a spike-in Stable Isotope Labeling by Amino acids in Cell culture (SILAC) experiment and derive an expression for phosphorylation occupancy. The experimental workflow provides the foundation for the mathematical model.\n\n**Experimental Design:**\n1.  Two populations of cells are cultured. The reference population, representing the baseline state, is grown in a medium containing heavy-isotope-labeled amino acids (e.g., $({}^{13}\\text{C}_6, {}^{15}\\text{N}_2)$-Lysine and $({}^{13}\\text{C}_6, {}^{15}\\text{N}_4)$-Arginine). This results in a proteome where essentially all proteins are 'heavy'. The experimental population is grown in standard 'light' medium.\n2.  The 'light' culture is subjected to the stimulus, while the 'heavy' culture is not.\n3.  After stimulation, cells from both cultures are harvested and lysed. A fixed amount of the heavy reference proteome (the 'spike-in') is mixed with the light experimental sample proteome.\n4.  The combined protein mixture undergoes enzymatic digestion (e.g., with trypsin) to generate peptides.\n5.  The resulting peptide mixture is analyzed by liquid chromatography-mass spectrometry (LC-MS). The mass spectrometer measures the signal intensity for the light and heavy isotopic forms of both the phosphorylated peptide and its unphosphorylated counterpart.\n\n**Derivation from First Principles:**\n\nLet the molar amount of the phosphorylated peptide in the stimulated (light) sample be $P_s$ and in the reference (heavy) sample be $P_r$.\nLet the molar amount of the unphosphorylated (nonmodified) peptide in the stimulated (light) sample be $U_s$ and in the reference (heavy) sample be $U_r$.\n\nThe phosphorylation occupancy, $p$, is defined as the fraction of the total peptide pool that is phosphorylated:\n$$p = \\frac{P}{P + U}$$\nThus, for the stimulated and reference samples, we have:\n$$p_s = \\frac{P_s}{P_s + U_s}$$\n$$p_r = \\frac{P_r}{P_r + U_r}$$\n\nThe total amount of the site-containing peptide (phosphorylated plus unphosphorylated) in each sample is denoted by $T$:\n$$T_s = P_s + U_s$$\n$$T_r = P_r + U_r$$\n\nFrom these definitions, we can express the individual amounts in terms of total amounts and occupancies:\n$P_s = p_s T_s$ and $U_s = (1 - p_s) T_s$\n$P_r = p_r T_r$ and $U_r = (1 - p_r) T_r$\n\nAccording to the problem's assumption (ii), the mass spectrometer signal, $S$, for a given peptide is proportional to its molar amount multiplied by a response factor, $C$. This response factor depends on the chemical form of the peptide (i.e., phosphorylated vs. unphosphorylated) but is identical for light and heavy isotopologs of the same chemical form. Let $C_P$ be the response factor for the phosphorylated peptide and $C_U$ be the response factor for the unphosphorylated peptide. In general, $C_P \\neq C_U$ due to differences in ionization efficiency.\n\nThe measured signals for the four peptide species are:\n-   Signal for light phosphorylated peptide: $S_{P,s} = C_P \\cdot P_s$\n-   Signal for heavy phosphorylated peptide: $S_{P,r} = C_P \\cdot P_r$\n-   Signal for light unphosphorylated peptide: $S_{U,s} = C_U \\cdot U_s$\n-   Signal for heavy unphosphorylated peptide: $S_{U,r} = C_U \\cdot U_r$\n\nThe experiment measures the light-to-heavy signal ratios for the phosphorylated and unphosphorylated peptides, denoted as $R_P$ and $R_U$, respectively.\nThe ratio for the phosphorylated peptide is:\n$$R_P = \\frac{S_{P,s}}{S_{P,r}} = \\frac{C_P \\cdot P_s}{C_P \\cdot P_r} = \\frac{P_s}{P_r}$$\nThe ratio for the unphosphorylated peptide is:\n$$R_U = \\frac{S_{U,s}}{S_{U,r}} = \\frac{C_U \\cdot U_s}{C_U \\cdot U_r} = \\frac{U_s}{U_r}$$\nCritically, the response factors $C_P$ and $C_U$ cancel out in these ratios. This is the key feature of the SILAC method that allows for accurate quantification independent of peptide-specific ionization efficiencies, thus fulfilling a core requirement of the problem.\n\nNow, we substitute the expressions for $P_s, P_r, U_s, U_r$ into the ratio equations:\n$$R_P = \\frac{p_s T_s}{p_r T_r}$$\n$$R_U = \\frac{(1 - p_s) T_s}{(1 - p_r) T_r}$$\n\nThese two equations contain the unknown ratio of total peptide amounts, $\\frac{T_s}{T_r}$. This term encapsulates both the biological change in the protein's expression level and the experimental mixing ratio of the light and heavy proteomes. To find $p_s$, we must eliminate this nuisance term. We can rearrange both equations to solve for $\\frac{T_s}{T_r}$:\nFrom the $R_P$ equation:\n$$\\frac{T_s}{T_r} = R_P \\frac{p_r}{p_s}$$\nFrom the $R_U$ equation:\n$$\\frac{T_s}{T_r} = R_U \\frac{1 - p_r}{1 - p_s}$$\n\nBy equating these two expressions for $\\frac{T_s}{T_r}$, we eliminate the unknown total amounts:\n$$R_P \\frac{p_r}{p_s} = R_U \\frac{1 - p_r}{1 - p_s}$$\nNow, we must solve this equation for $p_s$.\n$$R_P \\cdot p_r \\cdot (1 - p_s) = R_U \\cdot (1 - p_r) \\cdot p_s$$\n$$R_P p_r - R_P p_r p_s = R_U (1 - p_r) p_s$$\n$$R_P p_r = R_U (1 - p_r) p_s + R_P p_r p_s$$\n$$R_P p_r = p_s [R_U (1 - p_r) + R_P p_r]$$\n\nThis yields the final closed-form expression for $p_s$:\n$$p_s = \\frac{R_P p_r}{R_U (1 - p_r) + R_P p_r}$$\nThis expression for the phosphorylation occupancy in the stimulated sample, $p_s$, depends only on the experimentally measured ratios $R_P$ and $R_U$, and the known occupancy of the reference sample, $p_r$.\n\n**Calculation:**\nThe problem provides the following measured and known values:\n$R_P = 3.2$\n$R_U = 0.80$\n$p_r = 0.25$\n\nFirst, calculate $1 - p_r$:\n$1 - p_r = 1 - 0.25 = 0.75$\n\nSubstitute these values into the derived expression:\n$$p_s = \\frac{(3.2) \\cdot (0.25)}{(0.80) \\cdot (0.75) + (3.2) \\cdot (0.25)}$$\nCalculate the terms in the numerator and denominator:\nNumerator: $3.2 \\times 0.25 = 0.8$\nDenominator term 1: $0.80 \\times 0.75 = 0.6$\nDenominator term 2: $3.2 \\times 0.25 = 0.8$\nSum of denominator terms: $0.6 + 0.8 = 1.4$\n\nSo, the expression becomes:\n$$p_s = \\frac{0.8}{1.4}$$\nTo express this as an exact fraction:\n$$p_s = \\frac{0.8}{1.4} = \\frac{8}{14} = \\frac{4}{7}$$\nThe phosphorylation occupancy in the stimulated sample is precisely $\\frac{4}{7}$.", "answer": "$$\\boxed{\\frac{4}{7}}$$", "id": "2839183"}, {"introduction": "Beyond measuring PTMs, a central goal is to understand their function, often by using genetic mutations as mimics of the modified or unmodified state. However, such mimics can introduce unintended artifacts, leading to flawed conclusions if not interpreted with care. This exercise ([@problem_id:2839205]) requires a rigorous chemical and structural critique of a common acetylation mimic, pushing you to think like an experimentalist and identify truly orthogonal controls that isolate the function of the modification itself.", "problem": "A transcription factor that binds DNA is regulated by lysine acetylation on a single surface-exposed residue. A common genetic strategy replaces the lysine with glutamine to approximate the charge-neutral state associated with acetylation. Your task is to evaluate whether this substitution is a valid mimic and to identify a rigorous orthogonal control that isolates the chemical effect of acetylation at that single site.\n\nUse only the following fundamental bases in your reasoning: the Central Dogma of Molecular Biology (deoxyribonucleic acid to ribonucleic acid to protein), standard side-chain chemistry of amino acids, Bronsted–Lowry acid–base principles and pK values, and hydrogen-bonding donor/acceptor definitions. In particular, assume that at physiological pH (approximately $7.4$): unmodified lysine has a side-chain pK of approximately $10.5$ and is predominantly protonated and positively charged; acetylation converts the $\\varepsilon$-amino group into a neutral amide; and bromodomains recognize acetyl-lysine via a conserved asparagine that forms a hydrogen bond to the amide carbonyl and hydrophobic contacts to the acetyl methyl group.\n\nA researcher observes that replacing the target lysine with glutamine reduces DNA binding affinity by approximately $10$-fold, and concludes that acetylation weakens DNA binding. You are asked to critique this inference by analyzing the side-chain geometry and hydrogen-bonding capacity of glutamine versus acetyl-lysine, and by proposing an orthogonal control that specifically tests the chemical effect of acetylation at that site without introducing confounding geometric changes.\n\nWhich of the following statements are most accurate and appropriate for this purpose? Select all that apply.\n\nA. Lysine-to-glutamine preserves side-chain length and maintains exactly one hydrogen-bond donor and one acceptor oriented equivalently to acetyl-lysine, so it is a faithful structural and chemical mimic for acetylation.\n\nB. Lysine-to-glutamine removes the positive charge but shortens the side chain by approximately two methylene units and reorients the terminal amide; glutamine’s terminal amide typically presents two N–H donors and one carbonyl acceptor, whereas acetyl-lysine presents one N–H donor and one carbonyl acceptor adjacent to a methyl group in a different geometric context. Therefore, local packing and hydrogen-bonding can be perturbed independently of acetylation. A rigorous orthogonal control is to encode $\\varepsilon$-acetyl-lysine at the site using an engineered pyrrolysyl–transfer ribonucleic acid synthetase/transfer ribonucleic acid pair and an amber stop codon, yielding the native acetyl amide at that position.\n\nC. Lysine-to-glutamine retains the ability to be deacetylated by lysine deacetylases (histone deacetylases or sirtuins), preserving dynamic turnover and thus serving as a dynamic mimic of the acetylated state.\n\nD. An orthogonal chemical acetylation control is to mutate the lysine to cysteine and then treat the protein with $N$-acetylimidazole to selectively acetylate the introduced thiol, which reproduces both the electrostatics and bromodomain recognition features of acetyl-lysine at that site.\n\nE. An orthogonal approach is to reconstruct the protein with a native $\\varepsilon$-acetyl-lysine at the target position by semi-synthesis via expressed protein ligation between a synthetic peptide bearing acetyl-lysine and a recombinant fragment, producing a native amide at the site without altering side-chain geometry elsewhere.", "solution": "The problem statement will be validated before proceeding to a solution.\n\n### Step 1: Extract Givens\n- A transcription factor's DNA binding is regulated by lysine acetylation on a single surface-exposed residue.\n- A genetic strategy replaces lysine (K) with glutamine (Q) to mimic the charge-neutral state of acetylated lysine (AcK).\n- The task is to evaluate this K-to-Q substitution as a valid mimic and identify a rigorous orthogonal control.\n- Reasoning must be based on: Central Dogma, standard amino acid side-chain chemistry, Brønsted-Lowry principles, and hydrogen-bonding definitions.\n- At physiological pH ($pH \\approx 7.4$):\n    - Lysine side-chain pK is approximately $10.5$; it is predominantly protonated ($-\\text{NH}_3^+$) and positively charged.\n    - Acetylation converts the $\\varepsilon$-amino group to a neutral amide ($-\\text{NHCOR}$).\n    - Bromodomains recognize acetyl-lysine via a conserved asparagine H-bond to the amide carbonyl and hydrophobic contacts to the acetyl methyl group.\n- An observation is provided: replacing the target lysine with glutamine reduces DNA binding affinity by approximately $10$-fold.\n- A conclusion is inferred from this observation: acetylation weakens DNA binding.\n- The objective is to critique this inference and propose a specific orthogonal control.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is firmly rooted in established principles of molecular biology, biochemistry, and organic chemistry. The description of lysine, its acetylation, its mimicry by glutamine, and the methods for introducing site-specific modifications (unnatural amino acid incorporation, protein semi-synthesis) are all standard concepts and techniques in the field. All chemical and biological statements are factually correct.\n- **Well-Posed:** The problem is clearly defined. It asks for a critical evaluation of a common experimental strategy and the proposal of a superior control. The information provided is sufficient to perform this evaluation based on the chemical structures of the amino acids in question. A unique and meaningful answer can be derived.\n- **Objective:** The language is technical and unbiased. It describes a scientific scenario and asks for a rigorous analysis.\n\n### Step 3: Verdict and Action\nThe problem statement is scientifically sound, well-posed, and objective. It contains no logical contradictions, unrealistic premises, or ambiguities. The problem is valid. A full analysis will be conducted.\n\n### Analysis of the Problem\nThe central scientific question is the validity of the inference that acetylation weakens DNA binding, based on the observation that a lysine-to-glutamine (K-to-Q) mutation weakens DNA binding. The validity of this inference rests on the assumption that glutamine (Q) is a faithful mimic of acetyl-lysine (AcK). We must first analyze the chemical and structural properties of the side chains of lysine (K), acetyl-lysine (AcK), and glutamine (Q).\n\n1.  **Lysine (K):** The side chain is $-(\\text{CH}_2)_4-\\text{NH}_3^+$. At physiological pH, it is long, flexible, and carries a positive charge. This charge is often critical for interacting with the negatively charged phosphate backbone of DNA.\n\n2.  **Acetyl-lysine (AcK):** The side chain is $-(\\text{CH}_2)_4-\\text{NH}-\\text{CO}-\\text{CH}_3$. Acetylation neutralizes the positive charge by converting the primary amine into an amide. The amide group introduces a hydrogen-bond donor (the $\\text{N}-\\text{H}$ group) and a hydrogen-bond acceptor (the carbonyl oxygen, $\\text{C}=\\text{O}$). It also adds a terminal hydrophobic methyl group ($-\\text{CH}_3$). The overall length of the carbon-nitrogen backbone of the side chain is preserved.\n\n3.  **Glutamine (Q):** The side chain is $-(\\text{CH}_2)_2-\\text{CO}-\\text{NH}_2$.\n    - **Charge:** The side chain is neutral, correctly mimicking the charge neutralization of acetylation.\n    - **Size and Geometry:** The side chain is substantially shorter than that of lysine or acetyl-lysine. It contains two methylene groups compared to four in lysine. The functional group, a primary amide, is located much closer to the protein backbone.\n    - **Hydrogen Bonding:** The terminal primary amide ($-(\\text{CO})\\text{NH}_2$) contains *two* hydrogen-bond donors (the two hydrogens on the nitrogen) and one hydrogen-bond acceptor (the carbonyl oxygen). This differs from the secondary amide of AcK, which has only *one* hydrogen-bond donor.\n\n**Critique of the K-to-Q Mimic:** The K-to-Q mutation is an imperfect mimic. While it correctly captures the neutralization of the positive charge, it introduces significant confounding structural changes:\n- It shortens the side chain by two atoms (specifically, two methylene units).\n- It alters the hydrogen-bonding potential (two donors for Q vs. one for AcK).\n- It changes the geometric presentation of the functional group relative to the protein backbone.\n\nTherefore, the observed $10$-fold reduction in DNA binding upon K-to-Q mutation could be due to the loss of positive charge, but it could also be due to these steric and hydrogen-bonding perturbations. The researcher's conclusion that acetylation *itself* weakens binding is not rigorously supported by this experiment alone.\n\n**Requirement for an Orthogonal Control:** A rigorous control must isolate the chemical consequences of adding an acetyl group to the native lysine side chain. The ideal experiment would introduce an $\\varepsilon$-N-acetyl-lysine residue at the specific site of interest, creating the authentic post-translational modification without any other alterations to the protein's primary sequence or geometry.\n\n### Option-by-Option Analysis\n\n**A. Lysine-to-glutamine preserves side-chain length and maintains exactly one hydrogen-bond donor and one acceptor oriented equivalently to acetyl-lysine, so it is a faithful structural and chemical mimic for acetylation.**\nThis statement is factually incorrect. The glutamine side chain, $-(\\text{CH}_2)_2-\\text{CO}-\\text{NH}_2$, is shorter than the acetyl-lysine side chain, $-(\\text{CH}_2)_4-\\text{NH}-\\text{CO}-\\text{CH}_3$. Glutamine's primary amide has two hydrogen-bond donors, not one. The geometry is not equivalent.\n**Verdict: Incorrect.**\n\n**B. Lysine-to-glutamine removes the positive charge but shortens the side chain by approximately two methylene units and reorients the terminal amide; glutamine’s terminal amide typically presents two N–H donors and one carbonyl acceptor, whereas acetyl-lysine presents one N–H donor and one carbonyl acceptor adjacent to a methyl group in a different geometric context. Therefore, local packing and hydrogen-bonding can be perturbed independently of acetylation. A rigorous orthogonal control is to encode ε-acetyl-lysine at the site using an engineered pyrrolysyl–transfer ribonucleic acid synthetase/transfer ribonucleic acid pair and an amber stop codon, yielding the native acetyl amide at that position.**\nThis statement provides a precise and accurate critique of the K-to-Q substitution, correctly identifying the differences in side-chain length, hydrogen-bonding potential, and overall geometry. It correctly concludes that these are confounding factors. The proposed control, using an engineered synthetase/tRNA pair for unnatural amino acid incorporation, is a state-of-the-art method to site-specifically introduce AcK into a protein during translation in a living cell. This method produces the authentic modified protein, thereby serving as a perfect orthogonal control to test the direct effect of acetylation.\n**Verdict: Correct.**\n\n**C. Lysine-to-glutamine retains the ability to be deacetylated by lysine deacetylases (histone deacetylases or sirtuins), preserving dynamic turnover and thus serving as a dynamic mimic of the acetylated state.**\nThis statement is biochemically false. Lysine deacetylases (KDACs) are enzymes that hydrolyze the amide bond of $\\varepsilon$-N-acetyl-lysine. The side chain of glutamine contains a carboxamide group that is an integral part of its structure, not a post-translational modification on a lysine scaffold. KDACs do not recognize or act upon glutamine residues. Therefore, Q is a static, non-reversible mimic and cannot be used to study dynamic turnover.\n**Verdict: Incorrect.**\n\n**D. An orthogonal chemical acetylation control is to mutate the lysine to cysteine and then treat the protein with $N$-acetylimidazole to selectively acetylate the introduced thiol, which reproduces both the electrostatics and bromodomain recognition features of acetyl-lysine at that site.**\nThis strategy is deeply flawed. A K-to-C mutation replaces the long, four-carbon chain of lysine with the much shorter methylene-thiol group of cysteine, $-(\\text{CH}_2)-\\text{SH}$. Chemical acetylation of the thiol would yield a thioester, $-(\\text{CH}_2)-\\text{S}-\\text{CO}-\\text{CH}_3$. While this is charge-neutral, the geometry is completely different from AcK. It lacks the four-carbon linker and the amide N-H hydrogen-bond donor. A bromodomain, which specifically recognizes the precise geometry and chemical features of AcK (including the amide group context and side-chain length), is extremely unlikely to recognize this thioacetyl-cysteine construct. This \"control\" introduces more structural artifacts than the K-to-Q mutation it aims to improve upon.\n**Verdict: Incorrect.**\n\n**E. An orthogonal approach is to reconstruct the protein with a native ε-acetyl-lysine at the target position by semi-synthesis via expressed protein ligation between a synthetic peptide bearing acetyl-lysine and a recombinant fragment, producing a native amide at the site without altering side-chain geometry elsewhere.**\nThis statement describes another powerful, rigorous, and established method to generate a protein with an authentic, site-specific modification. Expressed protein ligation (EPL) allows for the covalent joining of a synthetic peptide (which can be made with any desired modification, such as AcK) and a recombinantly expressed protein fragment. The result is a full-length protein containing the precise AcK modification at the native lysine position, with no other changes to the protein sequence. This, like the method in option B, is an ideal orthogonal control that directly tests the function of the modification itself.\n**Verdict: Correct.**", "answer": "$$\\boxed{BE}$$", "id": "2839205"}]}